Low grade inflammation in the rectum of patients with sporadic irritable bowel syndrome

Molecular Medicine Reports

Volumn 7, Issue 4, 2013, Pages 1081-1085

  Salhy, Magdy El ^a,b   Gundersen, Doris ^c   Hatlebakk, Jan Gunnar ^b   Hausken, Trygve ^b  

^a Stord Helse Fonna Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Helse Fonna ^*  (Norway)

Author keywords

Irritable bowel syndrome; Leucocytes; Low grade inflammation; Lymphocytes; Macrophages; Mast cells; Rectum; Sporadic

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER AIDED DESIGN; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IRRITABLE COLON; LAMINA PROPRIA; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; MALE; MAST CELL; MONOCYTE; PATHOGENICITY; RECTUM BIOPSY; RECTUM DISEASE; SEX RATIO;

ADOLESCENT; ADULT; AGED; BIOPSY; COLONOSCOPY; FEMALE; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MUCOUS MEMBRANE; RECTUM;

EID: 84875238684     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1320     Document Type: Article

References (36)

1. El-Salhy M, Gundersen D, Hatlebakk JG and Hausken T (eds): Irritable Bowel Syndrome. Nova Scientific Publishers, New York, NY, 2012.
2. Agréus L, Svärsudd K, Nygrén O and Tibblin G: Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109: 671-680, 1995.
3. Thompson WG and Heaton KW: Functional bowel disorders in apparently healthy people. Gastorenterology 79: 283-288, 1980.
4. Kennedy TM, Jones RH, Hungin AP, O'Flanagan H and Kelly P: Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population. Gut 43: 770-774, 1998.
5. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E, et al: U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 38: 1569-1580, 1993.
6. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR and Evans RW: Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 109: 1736-1741, 1995.
7. Hungin AP, Whorwell PJ, Tack J and Mearin F: The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 17: 643-650, 2003.
8. Jones R and Lydeard S: Irritable bowel syndrome in the general population. BMJ 304: 87-90, 1992.
9. Bordie AK: Functional disorders of the colon. J Indian Med Assoc 58: 451-456, 1972.
10. O'Keefe EA, Talley NJ, Zinsmeister AR and Jacobsen SJ: Bowel disorders impair functional status and quality of life in the elderly: a population-based study. J Gerontol A Biol Sci Med Sci 50: M184-M189, 1995.
11. Everhart JE and Renault PF: Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 100: 998-1005, 1991.
12. Wilson S, Roberts L, Roalfe A, Bridge P and Singh S: Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 54: 495-502, 2004.
13. Harvey RF, Salih SY and Read AE: Organic and functional disorders in 2000 gastroenterology outpatients. Lancet 1: 632-634, 1983.
14. Spiegel BM: The burden of IBS: looking at metrics. Curr Gastroenterol Rep 11: 265-269, 2009.
15. Thompson WG: A world view of IBS. In: Irritable Bowel Syndrome: Diagnosis and Treatment. Camilleri M and Spiller R (eds). Saunders Ltd., Philadelphia and London, pp17-26, 2002.
16. Quigley EM, Locke GR, Mueller-Lissner S, Paulo LG, Tytgat GN, Helfrich I and Schaefer E: Prevalence and management of abdominal cramping and pain: a multinational survey. Aliment Pharmacol Ther 24: 411-419, 2006.
17. Miller V, Whitaker K, Morris JA and Whorwell PJ: Gender and irritable bowel syndrome: the male connection. J Clin Gastroenterol 38: 558-560, 2004.
18. Whitehead WE, Burnett CK, Cook EW III and Taub E: Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 41: 2248-2253, 1996.
19. Gralnek IM, Hays RD, Kilbourne A, Naliboff B and Mayer EA: The impact of irritable bowel syndrome on health related quality of life. Gastroenterology 119: 654-660, 2000.
20. Huerta I, Hinojosa C, Santa Maria A and Schmulson M: Diferencias en la calidad de vida (CV) entre pacientes con sindrome de Intestino irritable (SII) y la poblacon mexicana evaluadas mediante el SF-36. Rev Mex Gastroenterol 66 (Suppl 2): 145-146, 2001 (In Spanish).
21. Schmulson M, Robles G, Kershenobich, Lopez-Ridaura R, Hinojosa C and Durate A: Los pacientes con trastornos funcionales digestivos (TFD) tienen major compromiso de la calidad de vida (CV) evaluadas por el SF-36 comparados con pacientes con hepatitis C y pancreatitis cronica. Rev Mex Gastroenterol 65 (Suppl-Resumenes): 50-51, 2000 (In Spanish).
22. Weston AP, Biddle WL, Bhatia PS and Miner PB Jr: Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38: 1590-1595, 1993.
23. O'Sullivan M, Clayton N, Breslin NP, Herman I, Bountra C, McLaren A and O'Morain CA: Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 12: 449-457, 2000.
24. Dunlop SP, Jenkins D, Neal KR and Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS. Gastroenterology 125: 1651-1659, 2003.
25. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM and Corinaldesi R: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 126: 693-702, 2004.
26. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47: 804-811, 2000.
27. Cremon C, Gargano L, Morselli-Labate AM, Santini D, Cogliandro RF, De Giorgio R, Stanghellini V, Corinaldesi R and Barbara G: Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 104: 392-400, 2009.
28. Dizdar V, Hanevik K, Lærum OD, Gilja OH, Langeland N and Hausken T: Duodenal mucosal lymphocytes in Giardia-induced functional gastrointestinal disorder. Presented at the 19th United European Gastroenterology Week (UEGW) (abstract P0996), 2011.
29. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F and Spiller RC: Functional bowel disorders. Gastroenterology 130: 1480-1491, 2006.
30. Ghoshal UC, Park H and Gwee KA: Bugs and irritable bowel syndrome: The good, the bad and the ugly. J Gastroenterol Hepatol 25: 244-251, 2010.
31. Mckeown ES, Parry D, Stansfield R, Barton JR and Welfare MR: Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection. Neurogastroenterol Motil 18: 839-843, 2006.
32. Longstreth CF, Hawkey CJ, Mayer EA, Jones RH, Naesdal J, Wilson IK, Peacock RA and Wiklund IK: Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther 15: 959-964, 2001.
33. Spiller R and Garsed K: Infection, inflammation and the irritable bowel syndrome. Dig Liver Dis 41: 844-849, 2009.
34. Wheatcroft J, Wakelin D, Smith A, Mahoney CR, Mawe G and Spiller R: Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction. Neurogastroenterol Motil 17: 863-870, 2005.
35. Wang LH, Fang XC and Pan GZ: Bacillary dysentery as a causative factor for irritable bowel syndrome and its pathogenesis. Gut 53: 1096-1101, 2004.
36. Lee KJ, Kim YB, Kim JH, Kwon HC, Kim DK and Cho SW: The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors. J Gastroenterol Hepatol 23: 1689-1694, 2008.